Search research articles
Contact Us
Filters
Showing results (1-10 of 188) with videos related to
Page
of 19
Sort By:
Current Hematologic Malignancy Reports
|
April 29, 2010
Update on developmental therapeutics for acute lymphoblastic leukemia
Malcolm A Smith
Pediatric Blood & Cancer
|
April 25, 2014
Lessons learned from adult clinical experience to inform evaluations of VEGF pathway inhibitors in children with cancer
Malcolm A Smith
Molecular Cancer Therapeutics
|
March 12, 2014
Sorafenib inhibits ABCG2 and overcomes irinotecan resistance--letter
Malcolm A Smith
Oncology (Williston Park, N.Y.)
|
November 11, 2003
Clinical trials refferal resource. Current clinical trials of new agents and novel therapies in pediatric leukemia and lymphoma
Malcolm A Smith, Mason Schoenfeldt
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2013
A proposal regarding reporting of in vitro testing results
Malcolm A Smith, Peter Houghton
Cancer
|
October 7, 2018
Will my child do better if she enrolls in a clinical trial?
Malcolm A Smith, Steven Joffe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 2004
A window on reality?
Malcolm A Smith, Barry D Anderson
Pediatric Clinics of North America
|
December 2, 2014
Remaining challenges in childhood cancer and newer targeted therapeutics
Malcolm A Smith, Gregory H Reaman
JNCI Cancer Spectrum
|
July 31, 2019
Prospects for Minimal Residual Disease as a Surrogate Endpoint in Pediatric Acute Lymphoblastic Leukemia Clinical Trials
Lisa M McShane, Malcolm A Smith
European Journal of Cancer (Oxford, England : 1990)
|
August 4, 2004
Commentary on "European collaboration in trials of new agents for children with cancer" by Ablett et al
Malcolm A Smith, Barry D Anderson
Page
of 19
Search research articles
Search
Showing results (1-10 of 188) with videos related to
Sort By:
Page
of 19
Current Hematologic Malignancy Reports
|
April 29, 2010
Update on developmental therapeutics for acute lymphoblastic leukemia
Malcolm A Smith
Pediatric Blood & Cancer
|
April 25, 2014
Lessons learned from adult clinical experience to inform evaluations of VEGF pathway inhibitors in children with cancer
Malcolm A Smith
Molecular Cancer Therapeutics
|
March 12, 2014
Sorafenib inhibits ABCG2 and overcomes irinotecan resistance--letter
Malcolm A Smith
Oncology (Williston Park, N.Y.)
|
November 11, 2003
Clinical trials refferal resource. Current clinical trials of new agents and novel therapies in pediatric leukemia and lymphoma
Malcolm A Smith, Mason Schoenfeldt
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2013
A proposal regarding reporting of in vitro testing results
Malcolm A Smith, Peter Houghton
Cancer
|
October 7, 2018
Will my child do better if she enrolls in a clinical trial?
Malcolm A Smith, Steven Joffe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 2004
A window on reality?
Malcolm A Smith, Barry D Anderson
Pediatric Clinics of North America
|
December 2, 2014
Remaining challenges in childhood cancer and newer targeted therapeutics
Malcolm A Smith, Gregory H Reaman
JNCI Cancer Spectrum
|
July 31, 2019
Prospects for Minimal Residual Disease as a Surrogate Endpoint in Pediatric Acute Lymphoblastic Leukemia Clinical Trials
Lisa M McShane, Malcolm A Smith
European Journal of Cancer (Oxford, England : 1990)
|
August 4, 2004
Commentary on "European collaboration in trials of new agents for children with cancer" by Ablett et al
Malcolm A Smith, Barry D Anderson
Page
of 19